- Research works
- 24 ▼ 84% vs 2013–17
- Citations
- 299 12.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 30% world 28%
Not ranked overall: CardioDx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at CardioDx (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Myocardial Infarction, Coronary Artery Disease, Magnetic Resonance Imaging, Cardiac Imaging, Myocardial Perfusion, Cardiovascular Disease, Atherosclerosis and Gene Expression.
- Guidelines
- Ideal Cardiovascular Health
- Machine Learning
- Myocardial Revascularization
- Diagnosis Criteria
- Percutaneous Coronary Intervention
- Normalization
- Public Health
- Gene Expression
- Cardiovascular Disease
- Cardiac Imaging
- Coronary Artery Disease
- Myocardial Infarction
- Magnetic Resonance Imaging
- Myocardial Perfusion
- Atherosclerosis
- Data Analysis
- Inflammation
- Obesity
- Coronary Stents
- International Myeloma Working Group
- Epidemiology
- Cardiovascular Health
- Graft Survival
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Myocardial Infarction4▲ 69×4 topics
- Coronary Artery Disease4▲ 139×2 topics
- Magnetic Resonance Imaging4▲ 41×3 topics
- Cardiac Imaging3▲ 100×1 topic
- Myocardial Perfusion3▲ 178×1 topic
- Cardiovascular Disease3▲ 10×9 topics
- Atherosclerosis2▲ 24×4 topics
- Gene Expression2▲ 14×5 topics
- Data Analysis2▲ 23×3 topics
- Public Health2▲ 5.4×3 topics
- Inflammation2▲ 2.8×10 topics
- Normalization2▲ 93×2 topics
- Obesity2▲ 8.3×4 topics
- Percutaneous Coronary Intervention2▲ 43×2 topics
- Coronary Stents1▲ 117×1 topic
- Diagnosis Criteria1▲ 193×1 topic
- International Myeloma Working Group1▲ 193×1 topic
- Myocardial Revascularization1▲ 117×1 topic
- Epidemiology1▲ 1.36×4 topics
- Machine Learning1▲ 2.5×4 topics
- Cardiovascular Health1▲ 25×1 topic
- Ideal Cardiovascular Health1▲ 215×1 topic
- Graft Survival1▲ 40×3 topics
- Guidelines1▲ 8.9×4 topics
Which research topics does CardioDx (United States) publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Organ Transplantation Techniques and Outcomes, Renal Transplantation Outcomes and Treatments and Advanced Neural Network Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 1 works
- 2 Organ Transplantation Techniques and Outcomes Surgery 0 works
- 3 Renal Transplantation Outcomes and Treatments Transplantation 0 works
- 4 Advanced Neural Network Applications Computer Vision and Pattern Recognition 0 works
- 5 Xenotransplantation and immune response Surgery 0 works
- 6 Autonomous Vehicle Technology and Safety Automotive Engineering 0 works
- 7 Cancer Genomics and Diagnostics Cancer Research 0 works
- 8 Industrial Vision Systems and Defect Detection Industrial and Manufacturing Engineering 0 works
- 9 Acute Myeloid Leukemia Research Hematology 0 works
- 10 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CardioDx (United States)'s research output changed?
Output in 2018–2022 was 84% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Redwood City
- Heron Therapeutics (United States)
- Chan Zuckerberg Initiative (United States)
- Emergency University
- Guardant (United States)
- Box (United States)
- OncoMed (United States)
- Genomic Health (United States)
- Ubiquitous Energy (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.